301. Macular dystrophy Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 46 /  Drugs : 42 - (DrugBank : 11) / Drug target genes : 9 - Drug target pathways : 67

Macular dystrophy and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
IDDiseases (Sorted by drug repositionability)
301Macular dystrophy
299Cystic fibrosis
77Growth hormone secreting pituitary adenoma
65Primary immunodeficiency
85Idiopathic interstitial pneumonia
86Pulmonary arterial hypertension
13Multiple sclerosis/Neuromyelitis optica
265Lipodystrophy
225Congenital nephrogenic diabetes insipidus
113Muscular dystrophy
75Cushing disease
49Systemic lupus erythematosus
97Ulcerative colitis
2Amyotrophic lateral sclerosis
46Malignant rheumatoid arthritis
6Parkinson disease